The power of social networking in medicine

@article{Brownstein2009ThePO,
  title={The power of social networking in medicine},
  author={Catherine A. Brownstein and John S. Brownstein and David Sheldon Williams and Paul Wicks and James Heywood},
  journal={Nature Biotechnology},
  year={2009},
  volume={27},
  pages={888-890}
}
AcknowleDgemenTS We would like to acknowledge the valuable comments of Z. Lynch, B. Booth, K. Perampaladas and H. Masum in shaping the overall study design and G. Williams for study data. This study was supported by New Enterprise Associates. J.C. is funded by a grant from the Bill and Melinda Gates Foundation through the Grand Challenges in Global Health initiative. We also graciously thank all the venture capital firms for participating in our qualitative and quantitative analysis. 

Use of Social Media in Medicine: A Double-edged sword?

If properly and adequately used, within acceptable framework, SM can indeed be a boon, rather than a bane to medicine.

Social Media, Power, and the Future of VBAC

The role of social networks is examined in informing women about VBAC, producing low-cost, accessible decision aids, and enabling multi-stakeholder collaborations toward workable solutions that remove barriers women face in accessing VbAC.

The impact of social networks on health care

This work examines the risks and benefits stemming from the evolution of Social Network Services (SNSs) in the healthcare domain and study the impact of specific health-oriented social networks such as PatientsLikeMe.

The Evolving Role of Consumers

The culmination of the changes in health care, motivated in many ways by the rapid evolution of information and communication technologies in parallel with the shift toward increased patient decision

A Model for Social Network-Enhanced Health Communication

  • R. Steele
  • Medicine
    2011 IEEE Ninth International Conference on Dependable, Autonomic and Secure Computing
  • 2011
A model for social network-enhanced health communication is proposed and how this can assist health consumers in the population as a whole, those at risk of developing a condition, current sufferers of a specific health condition, clinicians, public health authorities, and health and medical researchers are described and analyzed.

The Potential Influence of Internet-Based Social Networking on the Conduct of Clinical Research Studies

Material posted in online health forums that could introduce bias into clinical research studies is identified and it is believed that this issue warrants further study and discussion.

The ethics of participant-led biomedical research

The author has advocated a scheme that seeks to meet this challenge by tailoring ethical oversight to the distinctive and pluralistic character of PLR, and suggested that if the entity conducting PLR is substantially equivalent to an ILR body, then standard ethical review should be mandatory.

Data Donation Could Power the Learning Health Care System, Including Special Access Programs

The ethical dimensions of special access programs for unapproved medical interventions in advance of regulatory approval are reviewed in ALS patients advocating fiercely for SAPs for a range of treatments.

Sharing Data for Public Health Research by Members of an International Online Diabetes Social Network

Success within an early adopter community demonstrates that online SNs may comprise efficient platforms for bidirectional communication with and data acquisition from disease populations and for use as a complementary surveillance approach.

What's up #DOC? The role of social media in diabetes management

It is suggested that the use of HRSMP improves patient capacity by increasing health literacy and decreases isolation by promoting peer interaction, and facilitates shared decision-making, which occurs when the patient and clinician jointly participate in a health decision.
...

References

SHOWING 1-5 OF 5 REFERENCES

Incidence of sexual side effects in refractory depression during treatment with citalopram or paroxetine.

Open-ended questions are an insufficient tool to estimate sexual dysfunction, and premarketing clinical trials should therefore include basic explicit assessments, and the failure to find a correlation between treatment duration and sexual dysfunction adds to the notion that sexual side effects due to SSRIs do not abate over time.

Calling all patients.

This telephone survey tool measures patient satisfaction based on empathy, communication, competence and continuity of care, and amenities.

Lithium delays progression of amyotrophic lateral sclerosis

It is found that daily doses of lithium, leading to plasma levels ranging from 0.4 to 0.8 mEq/liter, delay disease progression in human patients affected by ALS, and a marked neuroprotection by lithium is found, which delayed disease onset and duration and augmented the life span.